123I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes-Reference-Cited by-同舟云学术

123I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes

Published:2013-10-10 Issue:12 Volume:54 Page:2081-2086
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hellwig Sabine,Kreft Annabelle,Amtage Florian,Tüscher Oliver,Winz Oliver H.,Hellwig Bernhard,Weiller Cornelius,Weber Wolfgang A.,Vach Werner,Meyer Philipp T.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference40 articles.

1. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

2. Levodopa responsiveness in disorders with parkinsonism: A review of the literature

3. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

4. Stowe R Ives N Clarke CE . Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson’s disease patients with motor complications. Cochrane Database Syst Rev. 2010;CD007166.

5. Trials of neuroprotective therapies for Parkinson’s disease: Problems and limitations

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SPECT Molecular Imaging in Atypical Parkinsonism;International Review of Neurobiology;2018

2. Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease;International Review of Neurobiology;2018

3. Advances in SPECT Methodology;International Review of Neurobiology;2018

4. Neuroimaging of Parkinson's disease: Expanding views;Neuroscience & Biobehavioral Reviews;2015-12

5. Imagerie cérébrale;La maladie de Parkinson;2015